Skip to content

Study of kitibh kushtha with Rajrajeshwar ras orally and siddharthk Tailam topically

Randomized controlled clinical study to evaluate the efficacy of Rajrajeshwar Ras orally and Siddharthak Tailam topically in the management of Kitibh Kushtha with special refrance to Psoriasis in age group from 18-70 years. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075574
Enrollment
60
Registered
2024-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

DMM ayurved Mahavidyalaya Yavatmal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group above 18 and below 70 years. 2) Patient having classical signs and symptoms of kitibh kushtha Symptoms: - A) Kinakhara sparsha (Scaling), B) Ugrakandu (Severe pruritis) C) Parusha (Dryness), D) Srava (Dischange), E) Vritta (Oval to round Lesions), F) Ghana (Elevation), G) Shyawan (Greyish Discolouration), H) Snigdha Krushna (Erythematous Plaques) 3) Patient willing for clinical trial. Irrespective of gender, occupation, Religion, economical Barrier. 4) Patient who will fulfil criteria and take regular medicines with regular follow up.

Exclusion criteria

Exclusion criteria: 1) Age group below 18 years and above 70 years. 2) Pregnant and lactating mother. 3) Infective origins like a) Koch ‘s disease b) Hansen ‘s disease c) Scabies d) Eczema e) Fungal infection /herpes zoster. 4) Immune compromised like HIV 5) Diabetic wound 6) Malignancies 7) Renal diseases like CKD

Design outcomes

Primary

MeasureTime frame
In present clinical trial, the patients was diagnosed on the basis of signs and symptoms describe in ayurvedic text i. e subjective criteria A) Kinakhara sparsha (Scaling), B) Ugrakandu (Severe pruritis) C) Parusha (Dryness), D) Srava (Dischange), E) Vritta (Oval to round Lesions), F) Ghana (Elevation), G) Shyawan (Greyish Discolouration), H) Snigdha Krushna (Erythematous Plaques) Timepoint: Follow up on every 7th day in first 45 days (during treatment) and on every 15th day in Next 45 days (After treatment) up to the 3 months (90 days)

Secondary

MeasureTime frame
1)PASI Scale (Psoriasis Area And Severity Index) 2)DLQI Scale (Dermatology Life Quality Index) CBC ESR BSL Above investigations & other required investigations will be carried out to rule out Serious illness if any & whenever they are necessary. Timepoint: During treatment – 45 days (Follow up on 8th, 15th,22nd,29th,36th ,45th day) After treatment – 45 days (Follow up on 60th, 75th, 90th day)

Countries

India

Contacts

Public ContactDr Supriya Bhaskarrao Kadam

Department of Kayachikitsa, DMM ayurved Mahavidyalaya Yavatmal

dr.yogesh.duddalwar@gmail.com9423624476

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026